Sapheon, Inc. Announces Completed Enrollment in VenaSeal™ eSCOPE Study
9/12/2012 10:18:17 AM
More...
|
Sapheon, Inc. Holds First Close in $18.5 Million Series B
8/24/2012 7:57:59 AM
More...
|
Sapheon, Inc. Announces One Year Follow-up Data in 38-Patient Study of Varicose Vein Treatment
8/10/2012 10:07:35 AM
More...
|
Dieter Bielang Joins Sapheon, Inc. as International Sales Director, Europe
4/4/2012 9:20:06 AM
More...
|
Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study
1/19/2012 7:21:26 AM
More...
|
First German Patient Receives New Sapheon, Inc. Varicose Vein Treatment
10/19/2011 10:39:02 AM
More...
|
Sapheon, Inc. Receives CE Mark Approval for New Varicose Vein Treatment
9/22/2011 6:36:48 AM
More...
|